Breaking Finance News

Kepler Cheuvreux announced Brenntag (ETR:BNR), bumping up its stock price target to 52.00EUR today

Just yesterday Brenntag (ETR:BNR) traded 0.00% even at 48.85EUR. Brenntag’s 50-day moving average is 0.00EUR and its 200-day moving average is 0.00EUR. The last stock price is up 0.00% from the 200-day moving average, compared to the Standard & Poor's 500 Index which has decreased -0.01% over the same time period. 0 shares of BNR traded hands, down from an average trading volume of 0

In a report released on 09/29/2016 Kepler Cheuvreux increased the stock price target of Brenntag (ETR:BNR) to 52.00EUR reporting a possible upside of 0.06%.

Previously on 9/12/2016, HSBC released a statement about Brenntag (ETR:BNR) increased the target price from 0.00EUR to 43.00EUR. At the time, this indicated a possible downside of -0.09%.

Recent Performance Chart

Brenntag (ETR:BNR)

Brenntag has with a one year low of 0.00EUR and a one year high of 0.00EUR and has a market capitalization of 0 EUR.

General Information About Brenntag (ETR:BNR)

Brenntag AG is a Germany-based company active in the field of full-line chemical distribution. It provides business-to-business distribution solutions for industrial and specialty chemicals. The Company purchases and stores large-scale quantities of industrial and specialty chemicals and repackages them into smaller quantities. In addition, the Company also offers additional services, including delivery, product mixing, blending, repackaging, micronization and fine milling, inventory management and drum return handling, as well as technical and laboratory services for specialty chemicals. The Company offers its products to a range of market industries, such as adhesives, paints, oil & gas, food, water treatment, personal care and pharmaceuticals. The Company operates through a network with more than 450 locations in Europe, North and Latin America, and in the Asia Pacific region. Its subsidiaries include, among others, Quimicas Merono SL.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with's FREE daily email newsletter.